NAVISTAR® THERMOCOOL® SF Catheter: Observational Study

NCT01585961 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 511

Last updated 2015-01-26

Study results available
· View outcomes & findings →

Summary

This is a prospective, interventional, observational, unblinded, single-arm, multicenter registry of younger and older subjects with drug refractory, recurrent, symptomatic paroxysmal atrial fibrillation.

Conditions

Interventions

DEVICE

Catheter Ablation (NAVISTAR® THERMOCOOL® SF Catheter)

Administer anesthesia according to standard EP lab protocol, assess the fluid status of the subject (after each liter of infusate), determine if diuresis is necessary, and treat accordingly.

Sponsors & Collaborators

  • Biosense Webster, Inc.

    lead INDUSTRY

Principal Investigators

  • Gery Tomassoni, MD · Central Baptist Hospital

  • Scott Pollak, MD · Florida Hospital - Orlando

  • Andy Tran, MD · Scottsdale Healthcare Research Institute

  • Saumil Oza, MD · St. Vincent's Ambulatory Care, Inc.

  • Steven Compton, MD · Alaska Heart Institute, LLC

  • Anshul Patel, MD · St. Joseph's Hospital of Atlanta

  • Robert Fishel, MD · JFK Medical Center

  • Kenneth Civello, MD · Cardiovascular Research Foundation of Louisiana

  • Gaurang Gandhi, MD · Bethesda North Hospital

  • Alexandru Costea, MD · University of Cincinnati

  • Sreedhar Billakanty, MD · Riverside Methodist Hospital

  • H. James Wang, MD · Florida Hospital Memorial Medical Center

  • John Harding, MD · Central Bucks Specialists, Ltd.

  • Mohammed Khan, MD · Alexian Brothers Medical Center

  • Vijay Jayachandran, MD · Baylor All Saints Medical Center

  • Sree Karanam, MD · Lutheran Medical Group, LLC

  • M. Craig Delaughter, MD · Plaza Medical Center

  • Mohammad Jazayeri, MD · Bellin Memorial Hospital, Inc.

  • Abdi Rasekh, MD · Texas Heart Institute at St. Luke's Episcopal Hospital

  • Scott Allison, MD · Heart Center Research, LLC

  • Alexander Mazur, MD · University of Iowa Hospital & Clinics

  • Dhanunjaya Lakkireddy, MD · University of Kansas Hospitals

  • Alan Wimmer, MD · St. Luke's Hospital Mid American Heart Institute

  • Ali Hamzei, MD · Scripps Clinical Research

  • Shalin Shah, MD · Largo Medical Center

  • Michael Kutayli, MD · Bryan LGH Heart Institute

  • John Mandrola, MD · Baptist Hospital

  • Stuart Beldner, MD · North Shore University Hospital

  • Joshua Moss, MD · University of Chicago

  • Greg Bashian, MD · Centennial Heart

  • Patrick Whalen, MD · Vanderbilt Heart and Vascular Institute

  • Angelo Biviano, MD · New York Presbyterian Hospital, Columbia University Medical Center

  • Hussam Abuissa, MD · The Cardiac Center of Creighton University

  • Sumeet Mainigi, MD · Albert Einstein Medical Center

  • Charles Athill, MD · San Diego Cardiac Center

  • Edward Gerstenfeld, MD · UCSF Medical Center

  • Michael Chisner, MD · Cardiology Associates of Savannah

  • Vijendra Swarup, MD · Arizona Heart Hospital

  • Ziad Issa, MD · Prairie Education and Research Cooperative

  • Tariq Salam, MD · Cardiac Study Center

  • Sung Lee, MD · Washington Adventist Hospital

  • M. Magdy Migeed, MD · Genesis Healthcare Systems

  • Jonathan Sussman, MD · Morristown Medical Center

  • Bengt Herweg, MD · Tampa General Hospital

  • Pierce Vatterott, MD · United Heart and Vascular Clinic

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-04-30
Primary Completion
2014-07-31
Completion
2014-07-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01585961 on ClinicalTrials.gov